Professor Bruce Mann is a Professor of Surgery at the University of Melbourne and a specialist breast surgeon. He was appointed the Director of the Combined RMH and Women’s Breast Service in 2007, and the Director of the VCCC Breast Tumour Stream in 2016.

His clinical interest relates to all those with suspected or proven early breast cancer, where he was involved in the introduction of sentinel node biopsy to Australia, the appropriate use of contrast imaging in early breast cancer and safe de-intensification of treatment for early beast cancer.

His research interests focus on optimising the early diagnosis and treatment of breast cancer. He is co-chair of the expert advisory group for the ROSA (Roadmap to Optimising Screening in Australia) project of the Cancer Council of Australia. He is the instigator and Principal Investigator of the PROSPECT trial, investigating the role on MRI in the selective omission of radiotherapy in early breast cancer, and the national PI of the UK-led POSNOC trial of omission of additional axillary treatment in those with limited disease in the sentinel nodes. He led an Australian validation study of the DCISionRT assay in DCIS and is PI of an Australian registry of this assay.